Margaret E. Tome

2.2k total citations
59 papers, 1.8k citations indexed

About

Margaret E. Tome is a scholar working on Molecular Biology, Oncology and Biochemistry. According to data from OpenAlex, Margaret E. Tome has authored 59 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Biochemistry. Recurrent topics in Margaret E. Tome's work include Genomics, phytochemicals, and oxidative stress (9 papers), Amino Acid Enzymes and Metabolism (8 papers) and Glutathione Transferases and Polymorphisms (8 papers). Margaret E. Tome is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (9 papers), Amino Acid Enzymes and Metabolism (8 papers) and Glutathione Transferases and Polymorphisms (8 papers). Margaret E. Tome collaborates with scholars based in United States, Germany and Kuwait. Margaret E. Tome's co-authors include Margaret M. Briehl, Ines Batinić‐Haberle, Melba C. Jaramillo, Eugene W. Gerner, Claire M. Payne, Thomas P. Davis, Robert T. Dorr, Thomas Efferth, Norbert W. Lutz and Kateřina Dvořáková and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Margaret E. Tome

59 papers receiving 1.7k citations

Peers

Margaret E. Tome
Faisal Thayyullathil United Arab Emirates
David R Grubb Australia
Sehamuddin Galadari United Arab Emirates
John T. Pinto United States
Margaret M. Briehl United States
Faisal Thayyullathil United Arab Emirates
Margaret E. Tome
Citations per year, relative to Margaret E. Tome Margaret E. Tome (= 1×) peers Faisal Thayyullathil

Countries citing papers authored by Margaret E. Tome

Since Specialization
Citations

This map shows the geographic impact of Margaret E. Tome's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margaret E. Tome with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margaret E. Tome more than expected).

Fields of papers citing papers by Margaret E. Tome

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margaret E. Tome. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margaret E. Tome. The network helps show where Margaret E. Tome may publish in the future.

Co-authorship network of co-authors of Margaret E. Tome

This figure shows the co-authorship network connecting the top 25 collaborators of Margaret E. Tome. A scholar is included among the top collaborators of Margaret E. Tome based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margaret E. Tome. Margaret E. Tome is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tome, Margaret E., Dean Billheimer, Catherine Spier, et al.. (2024). Optimizing assessment of CD30 expression in Hodgkin lymphoma by controlling for low expression.. PubMed. 39(3). 319–331. 1 indexed citations
2.
Largent‐Milnes, Tally M., et al.. (2018). Chronic morphine exposure potentiates p-glycoprotein trafficking from nuclear reservoirs in cortical rat brain microvessels. PLoS ONE. 13(2). e0192340–e0192340. 15 indexed citations
3.
Tome, Margaret E., et al.. (2017). The opioid epidemic: a central role for the blood brain barrier in opioid analgesia and abuse. Fluids and Barriers of the CNS. 14(1). 32–32. 60 indexed citations
4.
Davis, Thomas P., et al.. (2014). P-glycoprotein Trafficking as a Therapeutic Target to Optimize CNS Drug Delivery. Advances in pharmacology. 71. 25–44. 51 indexed citations
5.
Lee, Kristy, Matthew R. Hart, Margaret M. Briehl, Andrew P. Mazar, & Margaret E. Tome. (2014). The copper chelator ATN-224 induces caspase-independent cell death in diffuse large B cell lymphoma. International Journal of Oncology. 45(1). 439–447. 17 indexed citations
6.
Tome, Margaret E., Kristy Lee, Melba C. Jaramillo, & Margaret M. Briehl. (2012). Mitochondria are the primary source of the H2O2 signal for glucocorticoid-induced apoptosis of lymphoma cells. Experimental and Therapeutic Medicine. 4(2). 237–242. 20 indexed citations
7.
Jaramillo, Melba C., Margaret M. Briehl, James D. Crapo, Ines Batinić‐Haberle, & Margaret E. Tome. (2012). Manganese Porphyrin, MnTE-2-PyP5+, Acts as a Pro-Oxidant to Potentiate Glucocorticoid-Induced Apoptosis in Lymphoma Cells. Free Radical Biology and Medicine. 52(8). 1272–1284. 65 indexed citations
8.
Tome, Margaret E., Melba C. Jaramillo, & Margaret M. Briehl. (2011). Hydrogen peroxide signaling is required for glucocorticoid-induced apoptosis in lymphoma cells. Free Radical Biology and Medicine. 51(11). 2048–2059. 22 indexed citations
9.
Rimsza, Lisa M., Joseph M. Unger, Margaret E. Tome, & Michael LeBlanc. (2011). A Strategy for Full Interrogation of Prognostic Gene Expression Patterns: Exploring the Biology of Diffuse Large B Cell Lymphoma. PLoS ONE. 6(8). e22267–e22267. 7 indexed citations
10.
Jaramillo, Melba C., Jennifer B. Frye, James D. Crapo, Margaret M. Briehl, & Margaret E. Tome. (2009). Increased Manganese Superoxide Dismutase Expression or Treatment with Manganese Porphyrin Potentiates Dexamethasone-Induced Apoptosis in Lymphoma Cells. Cancer Research. 69(13). 5450–5457. 55 indexed citations
11.
Finch, Joanne S., Margaret E. Tome, Kevin Kwei, & G. Tim Bowden. (2005). Catalase reverses tumorigenicity in a malignant cell line by an epidermal growth factor receptor pathway. Free Radical Biology and Medicine. 40(5). 863–875. 27 indexed citations
12.
Tome, Margaret E., Norbert W. Lutz, & Margaret M. Briehl. (2004). Overexpression of catalase or Bcl-2 alters glucose and energy metabolism concomitant with dexamethasone resistance. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1693(1). 57–72. 29 indexed citations
13.
Tome, Margaret E., Norbert W. Lutz, & Margaret M. Briehl. (2003). Overexpression of catalase or Bcl-2 delays or prevents alterations in phospholipid metabolism during glucocorticoid-induced apoptosis in WEHI7.2 cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1642(3). 149–162. 20 indexed citations
14.
Lutz, Norbert W., Margaret E. Tome, Nanci R. Aiken, & Margaret M. Briehl. (2002). Changes in phosphate metabolism in thymoma cells suggest mechanisms for resistance to dexamethasone‐induced apoptosis. A 31P NMR spectroscopic study of cell extracts. NMR in Biomedicine. 15(5). 356–366. 14 indexed citations
15.
Tome, Margaret E. & Margaret M. Briehl. (2001). Thymocytes selected for resistance to hydrogen peroxide show altered antioxidant enzyme profiles and resistance to dexamethasone-induced apoptosis. Cell Death and Differentiation. 8(9). 953–961. 35 indexed citations
16.
Dvořáková, Kateřina, Claire M. Payne, Margaret E. Tome, et al.. (2000). Induction of oxidative stress and apoptosis in myeloma cells by the aziridine-containing agent imexon. Biochemical Pharmacology. 60(6). 749–758. 75 indexed citations
17.
Xie, Xiaozhen, Margaret E. Tome, & Eugene W. Gerner. (1997). Loss of Intracellular Putrescine Pool-Size Regulation Induces Apoptosis. Experimental Cell Research. 230(2). 386–392. 45 indexed citations
18.
Tome, Margaret E. & Eugene W. Gerner. (1997). Cellular Eukaryotic Initiation Factor 5A Content as a Mediator of Polyamine Effects on Growth and Apoptosis. Neurosignals. 6(3). 150–156. 36 indexed citations
19.
Tome, Margaret E., Steven M. Fiser, & Eugene W. Gerner. (1994). Consequences of aberrant ornithine decarboxylase regulation in rat hepatoma cells. Journal of Cellular Physiology. 158(2). 237–244. 25 indexed citations
20.
Tome, Margaret E., et al.. (1988). Hypusine Biosynthesis in Protein and its Biological Consequences. Advances in experimental medicine and biology. 250. 449–458. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026